Mike Doustdar

TrumpRx, of course, will be coming up soon as well, as well as, of course, the traditional channels that usually medicine is procured in U.S.

Let me take you back.

You know, 10 years ago, when we started the journey of putting a peptide into a pill, no one thought scientifically that is possible.

You have to remind your audience that pills are usually chemical entities, small molecules, and not proteins and peptides.

And often they have lower efficacy because of that.

When we decided to actually go this route, everyone thought scientifically this is impossible.

Then after that, when we proved them wrong, people thought that we cannot scale that because this is quite difficult to do, again, because it's a large molecule inside a pill.

Again, we have shown confidence that we are able to scale this more than enough for every single person who would want to take the pill, and we're ready for that.

And then, of course, lastly, people are writing us off that this would not be possible at an affordable

And I'm also very happy to say, once again, we are proving all of these skeptics wrong.

So I'm super excited that we have something that is borderline miracle, in my own humble opinion, a peptide and a pill with a high efficacy produced at scale.

And we're going to actually sell it through all channels at relatively affordable price.

You know, in my own family and circle of friends, there are a number of people that have been very attracted in taking a GLP-1 product and reducing weight.

Unfortunately, they have not, you know, taken that journey because they've been either afraid of injections or there's the taboo of injection.

I think a lot of these people today will be able to find Vigovipil incredibly interesting as a way, again, to come in, get the same efficacy as your injection,

but in a form factor of appeal.

So in short, I think the market will expand quite a bit, actually, for many of these people that have just been waiting and seeing the injectable versions of these GLP-1 products taking the world by storm.

Well, again, the whole negotiation with Trump's administration has been around providing access at an affordable price.

And we have announced that we will start the starting dose of the big OV pill at 149, which I think is a very affordable price for many Americans to get interested at.

And I will say that as we go forward, of course, we will very much